Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3

Wolfien, M.; Klatt, D.; Salybekov, A.A.; Ii, M.; Komatsu-Horii, M.; Gaebel, R.; Philippou-Massier, J.; Schrinner, E.; Akimaru, H.; Akimaru, E.; David, R.; Garbade, J.; Gummert, J.; Haverich, A.; Hennig, H.; Iwasaki, H.; Kaminski, A.; Kawamoto, A.; Klopsch, C.; Kowallick, J.T.; Krebs, S.; Nesteruk, J.; Reichenspurner, H.; Ritter, C.; Stamm, C.; Tani-Yokoyama, A.; Blum, H.; Wolkenhauer, O.; Schambach, A.; Asahara, T.; Steinhoff, G.

Journalpaper

Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3

Abstract

Background Bone marrow stem cell clonal dysfunction by somatic mutation is suspected to affect post-infarction myocardial regeneration after coronary bypass surgery (CABG). Methods Transcriptome and variant expression analysis was studied in the phase 3 PERFECT trial post myocardial infarction CABG and CD133+ bone marrow derived hematopoetic stem cells showing difference in left ventricular ejection fraction (∆LVEF) myocardial regeneration Responders (n=14; ∆LVEF +16% day 180/0) and Non-responders (n=9; ∆LVEF -1.1% day 180/0). Subsequently, the findings have been validated in an independent patient cohort (n=14) as well as in two preclinical mouse models investigating SH2B3/LNK antisense or knockout deficient conditions. Findings 1. Clinical: R differed from NR in a total of 161 genes in differential expression (n=23, q<0•05) and 872 genes in coexpression analysis (n=23, q<0•05). Machine Learning clustering analysis revealed distinct RvsNR preoperative gene-expression signatures in peripheral blood acorrelated to SH2B3 (p<0.05). Mutation analysis revealed increased specific variants in RvsNR. (R: 48 genes; NR: 224 genes). 2. Preclinical: SH2B3/LNK-silenced hematopoietic stem cell (HSC) clones displayed significant overgrowth of myeloid and immune cells in bone marrow, peripheral blood, and tissue at day 160 after competitive bone-marrow transplantation into mice. SH2B3/LNK−/− mice demonstrated enhanced cardiac repair through augmenting the kinetics of bone marrow-derived endothelial progenitor cells, increased capillary density in ischemic myocardium, and reduced left ventricular fibrosis with preserved cardiac function. 3. Validation: Evaluation analysis in 14 additional patients revealed 85% RvsNR (12/14 patients) prediction accuracy for the identified biomarker signature. Interpretation Myocardial repair is affected by HSC gene response and somatic mutation. Machine Learning can be utilized to identify and predict pathological HSC response.

DOI Link to Publication

URL: https://publications.hereon.de/id/40041/
Authors:Wolfien, M., Klatt, D., Salybekov, A.A., Ii, M., Komatsu-Horii, M., Gaebel, R., Philippou-Massier, J., Schrinner, E., Akimaru, H., Akimaru, E., David, R., Garbade, J., Gummert, J., Haverich, A., Hennig, H., Iwasaki, H., Kaminski, A., Kawamoto, A., Klopsch, C., Kowallick, J.T., Krebs, S., Nesteruk, J., Reichenspurner, H., Ritter, C., Stamm, C., Tani-Yokoyama, A., Blum, H., Wolkenhauer, O., Schambach, A., Asahara, T., Steinhoff, G.
Year:2020
In: EBioMedicine
Volume:57
Pages:102862
Publisher:Elsevier, Amsterdam
Type:Journalpaper
ISSN: 2352-3964
Cite as: Wolfien, M.; Klatt, D.; Salybekov, A.A.; Ii, M.; Komatsu-Horii, M.; Gaebel, R.; Philippou-Massier, J.; Schrinner, E.; Akimaru, H.; Akimaru, E.; David, R.; Garbade, J.; Gummert, J.; Haverich, A.; Hennig, H.; Iwasaki, H.; Kaminski, A.; Kawamoto, A.; Klopsch, C.; Kowallick, J.T.; Krebs, S.; Nesteruk, J.; Reichenspurner, H.; Ritter, C.; Stamm, C.; Tani-Yokoyama, A.; Blum, H.; Wolkenhauer, O.; Schambach, A.; Asahara, T.; Steinhoff, G.: Hematopoietic stem-cell senescence and myocardial repair - Coronary artery disease genotype/phenotype analysis of post-MI myocardial regeneration response induced by CABG/CD133+ bone marrow hematopoietic stem cell treatment in RCT PERFECT Phase 3. In: EBioMedicine. Vol. 57 (2020) 102862. (DOI: /10.1016/j.ebiom.2020.102862)